Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma
Clinical trial NCT00138229 · TERMINATED
Trial details
- NCT number
- NCT00138229
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.